Calithera Biosciences Inc (NASDAQ:CALA)
| 4.89 Delayed Data As of Nov 27 |  +0.06 / +1.24%Today’s Change | 2.99 Today|||52-Week Range 8.18 | -14.36% Year-to-Date |
Latest CALA News | Press Releases
No recent news for Calithera Biosciences Inc.
Today’s Trading
| Previous close | 4.83 |
| Today’s open | 4.87 |
| Day’s range | 4.78 - 4.92 |
| Volume | 8,692 |
| Average volume (3 months) | 558,274 |
| Market cap | $344.3M |
Data as of 12:59pm ET, 11/27/2020
Growth & Valuation
| Earnings growth (last year) | -27.26% |
| Earnings growth (this year) | +31.53% |
| Earnings growth (next 5 years) | +75.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.18 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRVLPrevail Therapeutics... | -0.14 | -1.38% |
| ALTAltimmune Inc | +0.36 | +3.57% |
| MGTAMagenta Therapeutics... | +0.13 | +1.89% |
| VSTMVerastem Inc | +0.29 | +17.06% |
Data as of 1:00pm ET, 11/27/2020
Financials
| Next reporting date | March 17, 2021 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$89.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
